Isodiol International Inc.
Isodiol International Inc.
Isodiol International Inc. ("Isodiol") is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions.
Isodiol has commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products.
Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its consumer products portfolio and continued international expansion into Latin America, Asia, and Europe.
Isodiol International Inc. (ISOL)
SEDAR Information
Company Info
Capitalization
Company Officers
News Releases
Bulletins
2020-1214 - Suspension – Isodiol International Inc. (ISOL)
le 10 decembre/December 2020
Effective immediately, Isodiol International Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontario Securities Commission and the British Columbia Securities Commission.
For more information about Cease Trade Orders, visit the Canadian Securities Administrators Cease Trade Order database at www.securities-administrators.ca
CSE Filings
Advertisement
Publicité
Upcoming Events
Tech Tuesdays
Investing in Psychedelics Series: Building Value Through IP
Wednesday, January 20, 2021 -
Health Tech Thursdays
